QC
TECH icon

Quadrature Capital’s Bio-Techne TECH Stock Holding History

Quadrature Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-35,871
Closed -$2.66M – 1215
2023
Q1 		$2.66M Buy
+35,871
New +$2.76M 0.07% 239
2022
Q4 		– Sell
-25,228
Closed -$1.79M – 1133
2022
Q3 		$1.79M Sell
25,228
-78,284
-76% -$6.76M 0.06% 276
2022
Q2 		$8.98M Buy
+103,512
New +$9.7M 0.37% 74
2022
Q1 		– Sell
-2,800
Closed -$362K – 977
2021
Q4 		$362K Buy
+2,800
New +$343K 0.02% 441
2021
Q1 		– Sell
-6,448
Closed -$512K – 1139
2020
Q4 		$512K Sell
6,448
-4,500
-41% -$326K 0.03% 480
2020
Q3 		$678K Buy
10,948
+3,748
+52% +$244K 0.04% 433
2020
Q2 		$475K Buy
+7,200
New +$431K 0.05% 394
2018
Q3 		– Sell
-12,000
Closed -$444K – 765
2018
Q2 		$444K Buy
+12,000
New +$458K 0.04% 335

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Quadrature Capital's TECH Position: Q2 2023 in Review

Quadrature Capital sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 35,871 shares — an estimated $2.66M sold.

Quadrature Capital first reported a position in TECH in Q2 2018 and held it in 8 quarters. The position peaked at $8.98M in Q2 2022. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

  • Quadrature Capital reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
  • Quadrature Capital sold 35,871 Bio-Techne shares in Q2 2023, an estimated $2.66M.
  • Quadrature Capital first reported a position in Bio-Techne in Q2 2018 and held it in 8 quarters.
  • Quadrature Capital's Bio-Techne position peaked at $8.98M in Q2 2022.
  • 529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Quadrature Capital's 13F filing for Q2 2023, filed 14 Aug 2023.